Patients aged 45 and over with vague symptoms will be offered new blood tests designed to detect hard-to-diagnose abdominal cancers. By identifying proteins or DNA fragments early, the trial aims to help doctors prioritise investigations for conditions that are often only found after they have spread - potentially improving survival rates for thousands of people.

About the AI positivity score